Cargando…
A controlled trial of quetiapine XR coadministration treatment of SSRI-resistant panic disorder
BACKGROUND: Open-label quetiapine coadministration with SSRI therapy, in a diagnostically mixed sample of comorbid anxiety patients, offered additional anxiolytic benefit. Therefore, we designed the following controlled trial to confirm these findings in a comorbid, SSRI-resistant, panic disorder (P...
Autores principales: | Goddard, Andrew W., Mahmud, Waqar, Medlock, Carla, Shin, Yong-Wook, Shekhar, Anantha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4570751/ https://www.ncbi.nlm.nih.gov/pubmed/26379759 http://dx.doi.org/10.1186/s12991-015-0064-0 |
Ejemplares similares
-
Venlafaxine extended release (XR) in the treatment of panic disorder
por: Kjernisted, Kevin, et al.
Publicado: (2007) -
A retrospective study of clinical usage of quetiapine XR and quetiapine IR in outpatients with schizophrenia in Denmark
por: Emborg, Charlotte, et al.
Publicado: (2012) -
Use of quetiapine XR and quetiapine IR in clinical practice for hospitalized patients with schizophrenia: a retrospective study
por: Eriksson, Lars, et al.
Publicado: (2012) -
A randomized, double-blind study of the efficacy and tolerability of extended-release quetiapine fumarate (quetiapine XR) monotherapy in patients with major depressive disorder
por: Wang, Gang, et al.
Publicado: (2014) -
Sexual obsessions and suicidal behaviors in patients with mood disorders, panic disorder and schizophrenia
por: Dell’Osso, Liliana, et al.
Publicado: (2012)